Home Newsfeeds UBS Downgrades Dorian LPG to Neutral, Announces $19 Price Target

UBS Downgrades Dorian LPG to Neutral, Announces $19 Price Target

UBS analyst Brian Reynolds downgrades Dorian LPG (NYSE:LPG) from Buy to Neutral and announces $19 price target.

byBenzinga Newsdesk

January 5, 2023

1 minute read

UBS analyst Brian Reynolds downgrades Dorian LPG (NYSE:LPG) from Buy to Neutral and announces $19 price target.

Ozempic But Without The Needles? Pharma Giants Rush To Bring Weight Loss Drugs In Pill Form: WSJ

By Benzinga Newsbot

June 25, 8:21 AM

Pharmaceutical giants are developing pill versions of popular injectable weight-loss drugs like Ozempic, aiming to appeal to needle-averse…

LLY

Twitter CEO Yaccarino Jumps On The Barbie Bandwagon, Shows Off Pink ‘X’ App Icon

By Rounak Jain

August 2, 10:21 AM

Twitter CEO Linda Yaccarino has joined the Barbie hype train, showing off a new pink-colored ‘X' app icon as the Barbie fever grips everyone.

GPS

How To Earn $500 A Month From ZIM Integrated Shipping Stock

By AJ Fabino

June 28, 12:26 PM

Jefferies Financial Group on Tuesday maintained ZIM Integrated Shipping Services Ltd (NYSE:ZIM) with a Hold rating, but lowered…

ZIM

Legal
News

Corcept Therapeutics To Pay $14M On Proposed Settlement Of Purported Securities Class Action

By Benzinga Newsdesk

February 13, 9:05 AM

Corcept has reached a preliminary settlement of all claims in the purported securities class action against Corcept and certain of its executive officers captioned Melucci v. Corcept Therapeutics Incorporated,

CORT

UBS Downgrades Dorian LPG to Neutral, Announces $19 Price Target

Related Posts

Ozempic But Without The Needles? Pharma Giants Rush To Bring Weight Loss Drugs In Pill Form: WSJ

Twitter CEO Yaccarino Jumps On The Barbie Bandwagon, Shows Off Pink ‘X’ App Icon

How To Earn $500 A Month From ZIM Integrated Shipping Stock

Corcept Therapeutics To Pay $14M On Proposed Settlement Of Purported Securities Class Action